(Q39218023)
Statements
1 reference
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease (English)
1 reference
Hartmut Döhner
1 reference
Walter Fiedler
1 reference
Hubert Serve
1 reference
Michael Schwittay
1 reference
Oliver G Ottmann
1 reference
Anne-Marie O'Farrell
1 reference
Carlo L Bello
1 reference
Randy Allred
1 reference
William C Manning
1 reference
Julie M Cherrington
1 reference
Sharianne G Louie
1 reference
Weiru Hong
1 reference
Nicoletta M Brega
1 reference
Giorgio Massimini
1 reference
Paul Scigalla
1 reference
Wolfgang E Berdel
1 reference
Dieter K Hossfeld
1 reference
30 September 2004
1 reference
Identifiers
1 reference